Efficacy of intravitreal bevacizumab after unresponsive treatment with intravitreal ranibizumab

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

David M. Brown, Peter K. Kaiser, Mark Michels et al. · New England Journal of Medicine · 2006 · 3.5K citations

Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration

Robert L. Avery, Dante J. Pieramici, Melvin Rabena et al. · Ophthalmology · 2006 · 1.1K citations

Ocular Disease, Vitreous Body, Ophthalmology +2

An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration

Anne E. Fung, Geeta A. Lalwani, Philip J. Rosenfeld et al. · American Journal of Ophthalmology · 2007 · 966 citations

Ocular Disease, Vitreous Body, Optical Coherence Tomography-guided +6

Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration

Ziad F. Bashshur, Ali Bazarbachi, Alexandre Schakal et al. · American Journal of Ophthalmology · 2006 · 308 citations

Ocular Disease, Vitreous Body, Ophthalmology +7